Latest News

Read the latest news from 23Strands, media releases, journal articles and company announcements.

Entries for 'genetic sequencing'

Better Health Outcomes for All Australians – Medical Research Future Funding
Press Release

Better Health Outcomes for All Australians – Medical Research Future Funding

Sydney-based biotech start-up, 23Strands to play an integral and leading role in researching the benefit of genomic medicine to Indigenous Australians.
Leading this 5 year collaboration is Professor Alex Brown from the Australian National University who focussed on establishing the National Indigenous Genomics Network of research nodes to engage with Indigenous Australians in genetic research and health care in a culturally safe way.

23Strands in Support of White Shirt Day in the Fight against Ovarian Cancer
Cancer23

23Strands in Support of White Shirt Day in the Fight against Ovarian Cancer

23Strands is standing in solidarity in the fight against ovarian cancer. Ovarian cancer remains one of the most fatal cancers affecting women. Globally, a woman or girl who is diagnosed with ovarian cancer faces a 49% chance of surviving the next five years. Despite this, research in ovarian cancer persists to be disproportionately low in comparison to other fields of oncology.

Arc Linkage Program Team Spotlight
Press Release

Arc Linkage Program Team Spotlight

As part of a prestigious program to encourage research collaboration, 23Strands has secured funding in partnership with the University of Technology Sydney (UTS). The Australian Research Council’s Linkage Program (ARC LP) aims to encourage and extend cooperative approaches to research and encourages the transfer of skills, knowledge and ideas as a basis for securing commercial and other benefits of research.

AI Tool Eve Accurately Predicts Disease Relevance of Human Genetic Variants
Research News

AI Tool Eve Accurately Predicts Disease Relevance of Human Genetic Variants

Researchers at Harvard Medical School and Oxford University have now developed an artificial intelligence (AI) tool called EVE (evolutionary model of variant effect), which uses a sophisticated type of machine learning to detect patterns of genetic variation across hundreds of thousands of nonhuman species and then use them to make predictions about the meaning of variations in human genes.

Message in a Bottle
Cancer23

Message in a Bottle

The potential of mRNA technology goes well beyond COVID into some of our most prevalent diseases, from the flu to heart disease and even cancer.